Literature DB >> 3409975

Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells.

C Van den Bogert1, P Muus, C Haanen, A Pennings, T E Melis, A M Kroon.   

Abstract

Mitochondrial (mt) biogenesis and mt function were investigated during the cell cycle of leukemic cells. The study shows that the activity of enzymes involved in oxidative phosphorylation increases in the early G1 phase. This increase in activity precedes that of other mt enzymes such as citrate synthase and adenylate kinase. Therefore, the synthesis of mt enzymes, needed for the reduplication of the mt mass in the course of the cell cycle, occurs in a sequential order. The enzymes of the system for oxidative phosphorylation are composed of several subunits. Some of these subunits are encoded on mtDNA and synthesized by mt-specific RNA and protein synthesis. This explains why inhibition of mt protein synthesis during the progression of the cell cycle of G1-enriched cells results in an increasing shortage of ATP. This lack of ATP results first in progression delay and, subsequently, in a cell cycle block in early G1. Furthermore, shortage of ATP impairs the increase in activity of at least one mt matrix enzyme. This study offers new information about a number of aspects of mt biogenesis and mt function during cell cycle progression and elucidates the cytostatic mechanism resulting from prolonged inhibition of mt protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409975     DOI: 10.1016/0014-4827(88)90385-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

Review 1.  Mitochondrial biogenesis and healthy aging.

Authors:  Guillermo López-Lluch; Pablo M Irusta; Placido Navas; Rafael de Cabo
Journal:  Exp Gerontol       Date:  2008-07-09       Impact factor: 4.032

2.  Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells.

Authors:  Millie A Behera; Qunsheng Dai; Rachana Garde; Carrie Saner; Emily Jungheim; Thomas M Price
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

3.  Cellular redox-status is associated with regulation of frond division in Spirodela polyrrhiza.

Authors:  Georgia Moschopoulou; Iosif Papanastasiou; Olga Makri; Nikos Lambrou; Garyfallia Economou; Katerina Soukouli; Spiridon E Kintzios
Journal:  Plant Cell Rep       Date:  2007-08-09       Impact factor: 4.570

4.  Biogenesis and dynamics of mitochondria during the cell cycle: significance of 3'UTRs.

Authors:  Marta Martínez-Diez; Gema Santamaría; Alvaro D Ortega; José M Cuezva
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

5.  1-beta-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cells.

Authors:  P Muus; C Van den Bogert; H De Vries; A Pennings; M Holtrop; C Haanen
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

6.  Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA.

Authors:  Philippe A Parone; Sandrine Da Cruz; Daniel Tondera; Yves Mattenberger; Dominic I James; Pierre Maechler; François Barja; Jean-Claude Martinou
Journal:  PLoS One       Date:  2008-09-22       Impact factor: 3.240

7.  Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin.

Authors:  Sara Prosén; Anna Göthlin Eremo; Alexander Duarte Tsegai; Magnus Lindberg; Elisabet Tina
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

8.  Inference of protein complex activities from chemical-genetic profile and its applications: predicting drug-target pathways.

Authors:  Sangjo Han; Dongsup Kim
Journal:  PLoS Comput Biol       Date:  2008-08-29       Impact factor: 4.475

9.  Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3.

Authors:  Margherita Protasoni; Albert M Kroon; Jan-Willem Taanman
Journal:  Oncotarget       Date:  2018-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.